Epigral Ltd.
1,249.20+8.3 (+0.67%)
26 Aug, 3:30 PM
Income Statement
Abridged
Understanding Income Statement
Epigral Ltd. income statement covering revenue, operating profit, EBITDA, PAT and EPS across annual and quarterly periods.
Balance Sheet
Abridged
Understanding Balance Sheet
Epigral Ltd. balance sheet covering assets, liabilities, equity and borrowings across annual and quarterly periods.
Cash Flow
Abridged
Understanding Cash Flow Statement
Epigral Ltd. cash flow statement covering operating, investing and financing activities across annual and quarterly periods.
Business Segment Analysis
FY End:
Mar 26
Epigral Ltd. business segment breakdown covering revenue, operating income and assets across key divisions for the selected financial year.
Capex
Manufacturing of chlor alkali & its derivatives (100.0%)₹ 394.15 Cr
Revenue / Sales
Manufacturing of chlor alkali & its derivatives (100.0%)₹ 2,527.18 Cr
Assets
Manufacturing of chlor alkali & its derivatives (100.0%)₹ 3,505.30 Cr
Operating Income
Manufacturing of chlor alkali & its derivatives (100.0%)₹ 399.83 Cr
Regional Segment Analysis
FY End:
Mar 26
Epigral Ltd. geographic revenue split showing domestic and international market performance across revenue and income for the selected financial year.
Revenue / Sales
Within India (96.9%)₹ 2,418.30 CrOutside India (3.1%)₹ 77.18 Cr
Historical Segment Analysis
Track how Epigral Ltd. segment contributions have evolved over multiple financial years to see which divisions are growing, shrinking or gaining strategic importance.
Business
Frequently Asked Questions
What is the revenue of Epigral Ltd.?
The latest trailing twelve month revenue of Epigral Ltd. is ₹ 2,626.00 Cr, reflecting a 1-year growth of 4.81% and a 3-year CAGR of 7.56%. Annual and quarterly revenue trends are available in the Income Statement section.
What is the net profit of Epigral Ltd.?
The latest trailing twelve month net profit (PAT) of Epigral Ltd. is ₹ 271.02 Cr, with a 3-year earnings CAGR of -1.96%. Detailed profit history across annual and quarterly periods is in the Income Statement section.
What is the EBITDA of Epigral Ltd.?
The trailing twelve month EBITDA of Epigral Ltd. is approximately ₹ 413.23 Cr (based on an operating margin of 15.74%). EBITDA reflects core operating profitability before interest, taxes, depreciation and amortisation.
What is the EPS of Epigral Ltd.?
The trailing twelve month Earnings Per Share (EPS) of Epigral Ltd. is 62.82. EPS trends across annual and quarterly periods are visible in the Income Statement section.
What is the debt level of Epigral Ltd.?
The debt-to-equity ratio of Epigral Ltd. stands at 0.26. The interest coverage ratio is 7.40x, reflecting the company's ability to service debt from operating earnings. The full breakdown of total borrowings is in the Balance Sheet section.
What is the book value per share of Epigral Ltd.?
The estimated book value per share of Epigral Ltd. is 518.37 (derived from a P/B ratio of 2.41 and market price of ₹ 1,249.20), reflecting the net asset value attributable to each share. See the Balance Sheet section for a full breakdown.
What is the cash flow from operations of Epigral Ltd.?
The trailing twelve month operating cash flow of Epigral Ltd. is ₹ 387.62 Cr. Annual and quarterly cash flow data is available in the Cash Flow section of the Statements tab.
Does Epigral Ltd. report consolidated or standalone financials?
Epigral Ltd. reports consolidated financials. You can toggle between consolidated and standalone views using the switch at the top of each statement section.